Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Stryker (SYK) stock in plain English

Free brief · no signupStart here
SYKPublished Nov 12, 2026
Stryker Corp
Healthcare · Medical Devices
Manufactures and sells orthopedic implants, robotic arm assistance systems, surgical tools, and patient handling equipment.
Assets:
Mako robotic arm systeminstalled in thousands of orthopedic operating rooms globally
50,000 global employeessupporting direct hospital sales and field service operations
Major manufacturing siteslocated across Ireland, Germany, Puerto Rico, and the United States
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

64
OPS ScoreOperating finances
Latest quote
-1.59%$313.08
$119.19B
33.4×
$26.31B

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 12, 2026Quotes updated Nov 20, 04:05 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was SYK. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Stryker (SYK) do?

Stryker Corp (SYK) is a U.S.-listed company in Healthcare (Medical Devices). What it does: Manufactures and sells orthopedic implants, robotic arm assistance systems, surgical tools, and patient handling equipment. Supplies hospital systems directly with specialized joint implants, surgical instruments, and proprietary orthopedic. It is worth $119.19B on the market and sold $26.31B over the last year.

Market cap
$119.19B
P/E ratio
33.4×
Annual sales
$26.31B
Sector
Healthcare
Industry
Medical Devices
Brief updated
Nov 12, 2026

Brands and businesses behind SYK

  • Mako: Sells robotic surgical platforms and procedure-specific consumables used by surgeons for knee and hip replacements.
  • LIFEPAK: Produces automated external defibrillators and monitoring systems purchased by emergency medical teams and hospitals.
  • Vocera: Provides hands-free wearable communication badges and software licenses to coordinate clinical hospital staff.
  • Sage: Manufactures disposable oral care and skin hygiene products aimed at reducing hospital-acquired infections.

SYK’s flags, in plain English

Each flag is a number from Stryker’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 12, 2026.

Wide Gross Margin

Gross margin of 63.2% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.

Stupid Cash

Can pay this year's bills 2.2 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.

Fat Margins

Profit margin of 13.8%. The company keeps a healthy share of each sale as profit, which gives it room when costs jump.

Priced for Perfection

Priced at 33.4 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.

2 more green flags open with the free trial. Try it free for 7 days.

Questions about SYK

How big is Stryker?

Stryker’s market cap is $119.19B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $26.31B: what customers paid the company over the last year, before any costs.

What is SYK’s P/E ratio?

SYK’s P/E ratio is 33.4×. Investors pay about 33.4 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with SYK?

Rigorous FDA regulations expose the business to product liability litigation and mandatory recalls across its implant and instrument lines. That is one risk on Stryker’s card. Its first risk flag is Priced for Perfection, explained above. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Stryker’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. SYK’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card